New Market Expansion with Hemo Bioengineering Products for Neurology Care Area

On 8 March 2024, idsMED unveiled a new product, HEMOBIO at Jakarta’s National Brain Center Hospital, RS PON, making a mark in idsMED’s Neurology Care Area Market. In this workshop, idsMED liaised with HEMOBIO from China and neuro-interventional doctors from RS PON. The session also addressed the necessity for thrombectomy procedures in Indonesia.

The event’s highlight was a product trial showcasing HEMOBIO’s cutting-edge Intermediate Catheter and Aspiration Catheter. Organised by the Neuro Intervention Team, the trial was led by Dr Abrar and Dr Riki alongside the Cath lab experts to showcase the efficacy and precision of HEMOBIO’s innovative design.

As doctors provided feedback, their invaluable insights ensure that HEMOBIO meets the rigorous requirements of the medical community before its official launch. Anticipation for HEMOBIO’s refined version grew with each suggestion, promising to revolutionize neurology care and improve the quality of life for countless people.